Van Plew Daniel P sold REGN

February 14, 2024 · Form 4 insider transaction

Van Plew Daniel P sold 150 shares of Regeneron Pharmaceuticals, Inc. at $948.70 per share, a transaction worth $142.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
150
Price
$948.70
Total value
$142.3K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 14, 2024
Filing dateFebruary 16, 2024
Shares owned after21,065
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.

View the original Form 4 on SEC EDGAR